Voltar
Revisão Acesso aberto Produção Nacional Revisado por pares
BIBTEX RIS

Advanced MR Techniques for Preoperative Glioma Characterization: Part 1

2023; Wiley; Volume: 57; Issue: 6 Linguagem: Inglês

10.1002/jmri.28662

ISSN

1522-2586

Autores

Lydiane Hirschler, Nico Sollmann, Bárbara Schmitz‐Abecassis, Joana Pinto, Fatemehsadat Arzanforoosh, Frederik Barkhof, Thomas C. Booth, Marta Calvo‐Imirizaldu, Guilherme de Souza e Cassia, Marek Chmelík, Patricia Clement, Ece Ercan, María A. Fernández‐Seara, Julia Furtner, Elies Fuster‐García, Matthew Grech‐Sollars, Nazmiye Tugay Guven, Gökçe Hale Hatay, Golestan Karami, Vera C. Keil, Mina Kim, Johan A F Koekkoek, Simran Kukran, Laura Mancini, Ruben Emanuel Nechifor, Alpay Özcan, Esin Öztürk-Işık, Şenol Pişkin, Kathleen M. Schmainda, Siri Fløgstad Svensson, Chih‐Hsien Tseng, Saritha Unnikrishnan, Frans M. Vos, Esther A. H. Warnert, Moss Zhao, Radim Jančálek, Teresa Nunes, Kyrre E. Emblem, Marion Smits, Jan Petr, Gilbert Hangel,

Tópico(s)

Glioma Diagnosis and Treatment

Resumo

Preoperative clinical magnetic resonance imaging (MRI) protocols for gliomas, brain tumors with dismal outcomes due to their infiltrative properties, still rely on conventional structural MRI, which does not deliver information on tumor genotype and is limited in the delineation of diffuse gliomas. The GliMR COST action wants to raise awareness about the state of the art of advanced MRI techniques in gliomas and their possible clinical translation or lack thereof. This review describes current methods, limits, and applications of advanced MRI for the preoperative assessment of glioma, summarizing the level of clinical validation of different techniques. In this first part, we discuss dynamic susceptibility contrast and dynamic contrast-enhanced MRI, arterial spin labeling, diffusion-weighted MRI, vessel imaging, and magnetic resonance fingerprinting. The second part of this review addresses magnetic resonance spectroscopy, chemical exchange saturation transfer, susceptibility-weighted imaging, MRI-PET, MR elastography, and MR-based radiomics applications. Evidence Level: 3 Technical Efficacy: Stage 2.

Referência(s)